MICHAEL WEISER, M.D., PH.D.
Medical Practice at Thompson St, New York, NY
License number
New York 212033
Category
Medical Practice
Type
Obstetrics & Gynecology
Address
Address
55 Thompson St, New York, NY 10012
Phone
(212) 901-1999
Personal information
See more information about MICHAEL WEISER at radaris.comName
Address
Phone
44 Knollwood Rd, Huntington, NY 11743
349 Southport St, Ronkonkoma, NY 11779
8808 151St Ave APT 6C, Howard Beach, NY 11414
525 Trimmer Rd, Spencerport, NY 14559
6911 Yellowstone Blvd, Flushing, NY 11375
Organization information
See more information about MICHAEL WEISER at bizstanding.comMichael Weiser MD,PHD
12 E 86 St APT 201, New York, NY 10028
Industry:
Obgyn
Phone:
(212) 628-0018 (Phone)
Michael Weiser
Professional information
Director At Actin Biomed
Position:
Director at Foresight Biotherapeutics, Director at Archer Biosciences, Director at Actin Biomed, Director at Emisphere Technologies, Director at Chelsea Therapeutics, Director at Ziopharm Oncology
Location:
Greater New York City Area
Industry:
Biotechnology
Work:
Foresight Biotherapeutics
since Apr 2008
-
Director
Archer Biosciences
- Greater New York City Area since Mar 2008
-
Director
Actin Biomed
since Dec 2006
-
Director
Emisphere Technologies
- Greater New York City Area since 2005
-
Director
Chelsea Therapeutics
- Charlotte, North Carolina Area since 2004
-
Director
Ziopharm Oncology
- Greater Boston Area since 2003
-
Director
Education:
New York University 1982 - 1984
Marine Biological Laboratory 1983 - 1986
University of Vermont 1984 - 1987
B.A. Psychology Cornell University Medical College 1988 - 1992
Ph.D. (Molecular Neurobiology) NYU School of Medicine 1993 - 1997
M.D. (May 1997) NYU School of Medicine 1992 - 1994
NYU Medical Center 1997 - 1998
Marine Biological Laboratory 1983 - 1986
University of Vermont 1984 - 1987
B.A. Psychology Cornell University Medical College 1988 - 1992
Ph.D. (Molecular Neurobiology) NYU School of Medicine 1993 - 1997
M.D. (May 1997) NYU School of Medicine 1992 - 1994
NYU Medical Center 1997 - 1998
Michael Weiser - New York, NY
Work:
Command Performance Catering, Inc
Operations Manager La Barrique French Bistro & Wine Bar - New York, NY
Assistant Manager Fresh & Fast Burgers, LLC - New York, NY
Kitchen & Service Manager Starbucks Coffee Company - New York, NY
Hourly Manager/Shift Supervisor Command Performance Catering, Inc - New York, NY
Chef Jacqueline's Corner Cafe
Operations Manager La Barrique French Bistro & Wine Bar - New York, NY
Assistant Manager Fresh & Fast Burgers, LLC - New York, NY
Kitchen & Service Manager Starbucks Coffee Company - New York, NY
Hourly Manager/Shift Supervisor Command Performance Catering, Inc - New York, NY
Chef Jacqueline's Corner Cafe
Education:
Washington University in St Louis One Brookings Drive - St. Louis, MO
Bachelor's in Marketing Communications and Advertising Design
Bachelor's in Marketing Communications and Advertising Design
Skills:
Communications and Marketing; Administrative Support, including use of MS Office (Word, Excel, Powerpoint), Adobe Acrobat (PDF), Adobe Illustrator, PhotoShop, and QuarkXPress, POS systems including Starr, Windows, and Aloha, and Open Table.
Owner, Command Performance Catering, Inc.
Position:
Owner at Command Performance Catering, Inc.
Location:
Greater New York City Area
Industry:
Events Services
Work:
Command Performance Catering, Inc.
-
Owner
Education:
Washington University in St. Louis 1966 - 1970
Michael Weiser
Location:
Greater New York City Area
Industry:
Law Practice
Water Conservation Shower Valve
US Patent:
2012009, Apr 19, 2012
Filed:
Oct 14, 2010
Appl. No.:
12/904431
Inventors:
Ulric S. Todman - New York NY, US
Michael Richard Weiser - New York NY, US
Ulric A. Todman - , US
Michael Richard Weiser - New York NY, US
Ulric A. Todman - , US
International Classification:
F16K 1/00
US Classification:
251319
Abstract:
A pushbutton device that will stop the flow of water to the showerhead by closing a valve after the hot and cold water is mixed to the desired temperature and water force. This button will operate a simple “push-to-open/push-to-close” valve, which will interrupt the water flow to the showerhead. The button will be clearly marked PAUSE, and will be visible to the user. While the button will highly visible to the user, it will be mounted in low relief to the wall, with smooth and rounded surface and edges, and will not pose a danger to the user in the event of a slip in the shower. This invention is meant to enable the user to instantly change the amount of water used for showering, by allowing the user to immediately stop the water flow and re-start the flow, without the need to re-adjust the water temperature and water force. Once the temperature is set and the water force is achieved the user will able to stop and start the water without having to reset. The objective is to enable the user to save significant amounts of both water and the energy needed to heat the water to the desired showering temperature, without having to spend any time, at all, thinking about it.
Methods Of Treating Inflammatory Diseases With Ammonium Salts Of Ornitihine Derivatives
US Patent:
2005003, Feb 10, 2005
Filed:
Aug 6, 2003
Appl. No.:
10/634811
Inventors:
Lindsay Rosenwald - Lawrence NY, US
Michael Weiser - New York NY, US
Jason Stein - New York NY, US
Jeff Serbin - New York NY, US
Michael Weiser - New York NY, US
Jason Stein - New York NY, US
Jeff Serbin - New York NY, US
International Classification:
A61K031/525
US Classification:
514251000
Abstract:
The present invention relates to pharmaceutically active ornithine compounds, particularly to pharmaceutically acceptable ammonium salts of N-acyl derivatives of N(4-amino-4-deoxypteroyl)-L-ornithine compounds; and methods of treatment and pharmaceutical compositions that utilize or comprise one or more of such ammonium salts. The ammonium salts provided by the invention exhibit superior chemical stability than corresponding acidic N-acyl derivatives of N-acyl derivatives of N(4-amino-4-deoxypteroyl)-L-ornithine compounds.
Povidone Iodine, A Novel Alternative Preservative For Ophthalmic Compositions
US Patent:
2013025, Sep 26, 2013
Filed:
May 16, 2013
Appl. No.:
13/895815
Inventors:
Joseph A. Capriotti - Christiansted VI, US
C. Michael Samson - New York NY, US
Jason Stein - New York NY, US
Michael Weiser - New York NY, US
Mark Abelson - Andover MA, US
C. Michael Samson - New York NY, US
Jason Stein - New York NY, US
Michael Weiser - New York NY, US
Mark Abelson - Andover MA, US
Assignee:
FORESIGHT BIOTHERAPEUTICS, INC. - New York NY
International Classification:
A01N 43/36
US Classification:
424 7825
Abstract:
The invention includes a preserved ophthalmic preparation comprising povidone-iodine (PVP-I) at a concentration sufficient to preserve the ophthalmic preparation, and at least one member selected from the group consisting of a steroidal anti-inflammatory compound, a non-steroidal anti-inflammatory compound, an antibacterial compound, an anti-allergy compound, and an anti-glaucoma compound. The invention also includes adding PVP-I to an ophthalmic composition in order to preserve the composition, wherein the PVP-I is added at a concentration sufficient to preserve the composition.
Povidone Iodine, A Novel Alternative Preservative For Ophthalmic Compositions
US Patent:
2012002, Feb 2, 2012
Filed:
Jun 10, 2009
Appl. No.:
12/997374
Inventors:
Jason Stein - New York NY, US
Bo Liang - East Brunswick NJ, US
C. Michael Samson - New York NY, US
Joseph A. Capriotti - Las Palmas, ES
Michael Weiser - New York NY, US
Mark B. Abelson - Andover MA, US
Bo Liang - East Brunswick NJ, US
C. Michael Samson - New York NY, US
Joseph A. Capriotti - Las Palmas, ES
Michael Weiser - New York NY, US
Mark B. Abelson - Andover MA, US
Assignee:
Foresight Biotherapeutics, Inc. - New York NY
International Classification:
A01N 43/36, A01P 1/00, A61P 27/02
US Classification:
424 7832
Abstract:
The invention includes a preserved ophthalmic preparation comprising povidone-iodine (PVP-I) at a concentration sufficient to preserve the ophthalmic preparation, and at least one member selected from the group consisting of a steroidal anti-inflammatory compound, a non-steroidal anti-inflammatory compound, an antibacterial compound, an anti-allergy compound, and an anti-glaucoma compound. The invention also includes adding PVP-I to an ophthalmic composition in order to preserve the composition, wherein the PVP-I is added at a concentration sufficient to preserve the composition.
Non-Irritating Opthalmic Povidone-Iodine Compositions
US Patent:
2013017, Jul 11, 2013
Filed:
Dec 15, 2010
Appl. No.:
13/515987
Inventors:
Bo Liang - East Brunswick NJ, US
Joseph A. Capriotti - Christiansted VI, US
C. Michael Samson - New York NY, US
Jason Stein - New York NY, US
Michael Weiser - New York NY, US
Joseph A. Capriotti - Christiansted VI, US
C. Michael Samson - New York NY, US
Jason Stein - New York NY, US
Michael Weiser - New York NY, US
Assignee:
FORESIGHT BIOTHERAPEUTICS, INC. - New York NY
International Classification:
A61K 47/10, A61K 47/08, A61K 9/00, A61K 31/79, A61K 45/06
US Classification:
424 7804
Abstract:
Disclosed are compositions and methods comprising povidone-iodine and a cooling-effective amount of a chemical agent. The compositions are useful to relieve mild ocular irritation, enhance ocular comfort, and to provide a refreshing effect and improved sensation, when the povidone-iodine solution is applied to the eye.
Otic Compositions For The Treatment Of Infections Of The Internal And External Ear In Mammals
US Patent:
2013008, Apr 11, 2013
Filed:
May 8, 2012
Appl. No.:
13/466763
Inventors:
Joseph A. Capriotti - Provincia de Las Palmas, ES
Bo Liang - East Brunswick NJ, US
C. Michael Samson - New York NY, US
Jason Stein - New York NY, US
Michael Weiser - New York NY, US
Bo Liang - East Brunswick NJ, US
C. Michael Samson - New York NY, US
Jason Stein - New York NY, US
Michael Weiser - New York NY, US
Assignee:
Foresight Biotherapeutics, Inc. - New York NY
International Classification:
A61K 31/79, A61K 31/573
US Classification:
424 7807
Abstract:
Disclosed herein compositions including povidone-iodine (PVP-I) useful in the treatment of acute and chronic bacterial, viral and fungal infections of the internal, middle and external ear of mammals, including humans.